Logo image of 1JEN.MI

JENOPTIK AG (1JEN.MI) Stock Fundamental Analysis

BIT:1JEN - Euronext Milan - DE000A2NB601 - Common Stock - Currency: EUR

19.9  +19.9 (+Infinity%)

Fundamental Rating

5

1JEN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Electronic Equipment, Instruments & Components industry. While 1JEN has a great profitability rating, there are some minor concerns on its financial health. 1JEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 1JEN was profitable.
In the past year 1JEN had a positive cash flow from operations.
1JEN had positive earnings in each of the past 5 years.
In the past 5 years 1JEN always reported a positive cash flow from operatings.
1JEN.MI Yearly Net Income VS EBIT VS OCF VS FCF1JEN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

1JEN has a better Return On Assets (4.58%) than 69.81% of its industry peers.
With a decent Return On Equity value of 8.49%, 1JEN is doing good in the industry, outperforming 69.81% of the companies in the same industry.
The Return On Invested Capital of 1JEN (6.37%) is better than 69.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1JEN is in line with the industry average of 7.60%.
Industry RankSector Rank
ROA 4.58%
ROE 8.49%
ROIC 6.37%
ROA(3y)4.1%
ROA(5y)4.33%
ROE(3y)8.46%
ROE(5y)8.38%
ROIC(3y)6.49%
ROIC(5y)6.42%
1JEN.MI Yearly ROA, ROE, ROIC1JEN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

1JEN has a Profit Margin of 6.98%. This is amongst the best in the industry. 1JEN outperforms 81.13% of its industry peers.
In the last couple of years the Profit Margin of 1JEN has declined.
1JEN's Operating Margin of 12.17% is amongst the best of the industry. 1JEN outperforms 92.45% of its industry peers.
1JEN's Operating Margin has improved in the last couple of years.
1JEN's Gross Margin of 34.63% is in line compared to the rest of the industry. 1JEN outperforms 41.51% of its industry peers.
In the last couple of years the Gross Margin of 1JEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.17%
PM (TTM) 6.98%
GM 34.63%
OM growth 3Y7.43%
OM growth 5Y3.76%
PM growth 3Y0.05%
PM growth 5Y-8.32%
GM growth 3Y-1.07%
GM growth 5Y0.13%
1JEN.MI Yearly Profit, Operating, Gross Margins1JEN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1JEN is still creating some value.
The number of shares outstanding for 1JEN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1JEN has about the same amount of shares outstanding.
1JEN has a better debt/assets ratio than last year.
1JEN.MI Yearly Shares Outstanding1JEN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
1JEN.MI Yearly Total Debt VS Total Assets1JEN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

1JEN has an Altman-Z score of 2.83. This is not the best score and indicates that 1JEN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1JEN (2.83) is comparable to the rest of the industry.
1JEN has a debt to FCF ratio of 6.82. This is a slightly negative value and a sign of low solvency as 1JEN would need 6.82 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.82, 1JEN perfoms like the industry average, outperforming 58.49% of the companies in the same industry.
1JEN has a Debt/Equity ratio of 0.51. This is a neutral value indicating 1JEN is somewhat dependend on debt financing.
1JEN has a worse Debt to Equity ratio (0.51) than 64.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 6.82
Altman-Z 2.83
ROIC/WACC1.14
WACC5.6%
1JEN.MI Yearly LT Debt VS Equity VS FCF1JEN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

1JEN has a Current Ratio of 2.05. This indicates that 1JEN is financially healthy and has no problem in meeting its short term obligations.
1JEN's Current ratio of 2.05 is fine compared to the rest of the industry. 1JEN outperforms 64.15% of its industry peers.
A Quick Ratio of 1.00 indicates that 1JEN should not have too much problems paying its short term obligations.
1JEN has a Quick ratio (1.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1
1JEN.MI Yearly Current Assets VS Current Liabilites1JEN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

1JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.95%, which is quite good.
The Earnings Per Share has been decreasing by -3.62% on average over the past years.
Looking at the last year, 1JEN shows a quite strong growth in Revenue. The Revenue has grown by 8.14% in the last year.
The Revenue has been growing slightly by 5.02% on average over the past years.
EPS 1Y (TTM)18.95%
EPS 3Y20.89%
EPS 5Y-3.62%
EPS Q2Q%28.57%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y20.09%
Revenue growth 5Y5.02%
Sales Q2Q%9.44%

3.2 Future

The Earnings Per Share is expected to grow by 15.27% on average over the next years. This is quite good.
1JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.10% yearly.
EPS Next Y9.51%
EPS Next 2Y15.12%
EPS Next 3Y12.57%
EPS Next 5Y15.27%
Revenue Next Year5.06%
Revenue Next 2Y6.64%
Revenue Next 3Y6.4%
Revenue Next 5Y6.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1JEN.MI Yearly Revenue VS Estimates1JEN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
1JEN.MI Yearly EPS VS Estimates1JEN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.96, which indicates a correct valuation of 1JEN.
1JEN's Price/Earnings ratio is a bit cheaper when compared to the industry. 1JEN is cheaper than 62.26% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. 1JEN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 9.38, the valuation of 1JEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, 1JEN is valued a bit cheaper than 69.81% of the companies in the same industry.
1JEN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 14.96
Fwd PE 9.38
1JEN.MI Price Earnings VS Forward Price Earnings1JEN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1JEN.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1JEN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.39
EV/EBITDA 9.66
1JEN.MI Per share data1JEN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1JEN may justify a higher PE ratio.
1JEN's earnings are expected to grow with 12.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.57
PEG (5Y)N/A
EPS Next 2Y15.12%
EPS Next 3Y12.57%

3

5. Dividend

5.1 Amount

1JEN has a Yearly Dividend Yield of 1.28%. Purely for dividend investing, there may be better candidates out there.
1JEN's Dividend Yield is comparable with the industry average which is at 2.72.
With a Dividend Yield of 1.28, 1JEN pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

Dividend Growth(5Y)0%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1JEN pays out 22.59% of its income as dividend. This is a sustainable payout ratio.
DP22.59%
EPS Next 2Y15.12%
EPS Next 3Y12.57%
1JEN.MI Yearly Income VS Free CF VS Dividend1JEN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
1JEN.MI Dividend Payout.1JEN.MI Dividend Payout, showing the Payout Ratio.1JEN.MI Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

BIT:1JEN (7/10/2025, 7:00:00 PM)

19.9

+19.9 (+Infinity%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-08 2024-05-08/bmo
Earnings (Next)08-09 2024-08-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.14B
Analysts82.22
Price Target35.6 (78.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend0.3
Dividend Growth(5Y)0%
DP22.59%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.05%
Min EPS beat(2)-39.49%
Max EPS beat(2)11.39%
EPS beat(4)1
Avg EPS beat(4)-14.48%
Min EPS beat(4)-39.49%
Max EPS beat(4)11.39%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-2.98%
Max Revenue beat(2)4.37%
Revenue beat(4)2
Avg Revenue beat(4)0.06%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)4.37%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.96
Fwd PE 9.38
P/S 1.05
P/FCF 16.39
P/OCF 7.34
P/B 1.27
P/tB 5.71
EV/EBITDA 9.66
EPS(TTM)1.33
EY6.68%
EPS(NY)2.12
Fwd EY10.66%
FCF(TTM)1.21
FCFY6.1%
OCF(TTM)2.71
OCFY13.62%
SpS19.01
BVpS15.64
TBVpS3.49
PEG (NY)1.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.58%
ROE 8.49%
ROCE 9.6%
ROIC 6.37%
ROICexc 6.67%
ROICexgc 14.14%
OM 12.17%
PM (TTM) 6.98%
GM 34.63%
FCFM 6.39%
ROA(3y)4.1%
ROA(5y)4.33%
ROE(3y)8.46%
ROE(5y)8.38%
ROIC(3y)6.49%
ROIC(5y)6.42%
ROICexc(3y)6.82%
ROICexc(5y)7.08%
ROICexgc(3y)15.95%
ROICexgc(5y)14.93%
ROCE(3y)9.78%
ROCE(5y)9.66%
ROICexcg growth 3Y8.69%
ROICexcg growth 5Y0.66%
ROICexc growth 3Y11.42%
ROICexc growth 5Y-6.48%
OM growth 3Y7.43%
OM growth 5Y3.76%
PM growth 3Y0.05%
PM growth 5Y-8.32%
GM growth 3Y-1.07%
GM growth 5Y0.13%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 6.82
Debt/EBITDA 2.22
Cap/Depr 117.75%
Cap/Sales 7.87%
Interest Coverage 7.45
Cash Conversion 75.63%
Profit Quality 91.45%
Current Ratio 2.05
Quick Ratio 1
Altman-Z 2.83
F-Score7
WACC5.6%
ROIC/WACC1.14
Cap/Depr(3y)108.34%
Cap/Depr(5y)102.54%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.95%
Profit Quality(3y)95.83%
Profit Quality(5y)98.8%
High Growth Momentum
Growth
EPS 1Y (TTM)18.95%
EPS 3Y20.89%
EPS 5Y-3.62%
EPS Q2Q%28.57%
EPS Next Y9.51%
EPS Next 2Y15.12%
EPS Next 3Y12.57%
EPS Next 5Y15.27%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y20.09%
Revenue growth 5Y5.02%
Sales Q2Q%9.44%
Revenue Next Year5.06%
Revenue Next 2Y6.64%
Revenue Next 3Y6.4%
Revenue Next 5Y6.1%
EBIT growth 1Y13.04%
EBIT growth 3Y29.02%
EBIT growth 5Y8.96%
EBIT Next Year62%
EBIT Next 3Y26.08%
EBIT Next 5Y19.39%
FCF growth 1Y82.93%
FCF growth 3Y19.38%
FCF growth 5Y-3.19%
OCF growth 1Y67.08%
OCF growth 3Y22.92%
OCF growth 5Y4.33%